Oscar Segurado
Profile
Oscar Segurado worked as a Director of Medical Affairs at Abbott Biotherapeutics Corp., Head of Cardiovascular Medical Affairs Group at Abbott Laboratories, VP of Clinical Development and Medical Affairs at Becton, Dickinson & Co., and Chief Medical Officer at Crescendo Bioscience LLC.
He holds a doctorate degree from the University of Salamanca and Julius-Maximilians-Universität Würzburg.
Former positions of Oscar Segurado
| Companies | Position | End |
|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
Abbott Biotherapeutics Corp.
 Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Abbott Biotherapeutics Corp. engages in the identification and development of oncology therapeutics. The firm's products in development include Daclizumab, a monoclonal antibody in Phase IIb clinical studies that binds to the alpha chain of the interleukin-2 receptor on activated T cells; and Volociximab, a chimeric monoclonal antibody in Phase I clinical studies that inhibits the functional activity of a protein in activated endothelial cells. The company was founded in 2008 and is headquartered in Redwood City, CA. | Chief Tech/Sci/R&D Officer | - |
| BECTON, DICKINSON AND COMPANY | Chief Tech/Sci/R&D Officer | - |
Crescendo Bioscience LLC
 Crescendo Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | - |
Training of Oscar Segurado
| Julius-Maximilians-Universität Würzburg | Doctorate Degree |
| University of Salamanca | Doctorate Degree |
Experiences
Positions held
Linked companies
| Listed companies | 2 |
|---|---|
| BECTON, DICKINSON AND COMPANY | Health Technology |
| ABBOTT LABORATORIES | Health Technology |
| Private companies | 2 |
|---|---|
Crescendo Bioscience LLC
Crescendo Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA. | Commercial Services |
Abbott Biotherapeutics Corp.
Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Abbott Biotherapeutics Corp. engages in the identification and development of oncology therapeutics. The firm's products in development include Daclizumab, a monoclonal antibody in Phase IIb clinical studies that binds to the alpha chain of the interleukin-2 receptor on activated T cells; and Volociximab, a chimeric monoclonal antibody in Phase I clinical studies that inhibits the functional activity of a protein in activated endothelial cells. The company was founded in 2008 and is headquartered in Redwood City, CA. | Health Technology |
- Stock Market
- Insiders
- Oscar Segurado
